Bharat Biotech would get ₹65 crore to repurpose its new Bangalore facility to increase the capacity of Covaxin production.Maharashtra state-owned Haffkine will also be provided around ₹65 crore for setting up a facility to make the inactivated vaccine
The text above is a summary, you can read full article here.